Suppr超能文献

细胞毒性药物安全操作自我评估工具(Cyto-SAT):一种适用于低收入和中等收入国家的细胞毒性药物安全操作自我评估工具。

Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries.

作者信息

von Grünigen Sandrine, Geissbühler Antoine, Bonnabry Pascal

机构信息

Pharmacy, Geneva University Hospitals, Geneva, Switzerland.

Faculty of Medicine, Institute of Global Health, Geneva University, Geneva, Switzerland.

出版信息

J Oncol Pharm Pract. 2021 Sep;27(6):1422-1431. doi: 10.1177/1078155220956687. Epub 2020 Sep 17.

Abstract

INTRODUCTION

The handling of cytotoxic medicines is a high-risk process for human and environmental health. Considering the rising burden of cancer in low- and middle-income countries (LMICs), we aimed to develop, validate, and pilot test a self-assessment tool to support the implementation of safe handling practices and promote continuous quality improvement for cytotoxic drug management in LMICs.

METHODS

First, the self-assessment tool Cyto-SAT was developed and validated. Key sources on the safe handling of cytotoxic medicines were reviewed to derive items addressing safety and quality aspects at every stage of the process. A two-round online Delphi survey was conducted to validate and prioritize the items. The validation rules in the first and second rounds were defined as ≥65% and ≥75% agreement, respectively. Then, intended users in healthcare facilities in LMICs evaluated the Cyto-SAT tool in a pilot test. They were asked to fill out an online evaluation questionnaire.

RESULTS

Twenty-seven experts from 13 high-income countries and LMICs participated in the Delphi survey. Final expert consensus was achieved for 134/137 (97.8%) items. Consensus on priority was achieved for 52 of 134 (38.8%) items. The final Cyto-SAT tool comprises 134 items in 10 domains and 28 subdomains covering the whole cytotoxic drug handling process (https://pharmed.datapharma.ch/cyto-sat_en/). Staff from 34 institutions in 28 LMICs completed the Cyto-SAT evaluation. Almost all of them reported total agreement or agreement with its usefulness (96%), applicability (94%), usability (98%), and acceptability (97%).

CONCLUSION

Cyto-SAT is the first self-assessment tool designed to assist professionals in LMICs in the safe handling of cytotoxic drugs. The pilot test revealed that Cyto-SAT is a useful and highly appreciated tool that supports practice improvement in LMICs. Cyto-SAT will be used in an international survey to obtain a global overview of handling practices in various LMIC settings.

摘要

引言

细胞毒性药物的处理对人类健康和环境健康而言是一个高风险过程。鉴于低收入和中等收入国家(LMICs)癌症负担日益加重,我们旨在开发、验证并试点测试一种自我评估工具,以支持安全处理措施的实施,并促进LMICs细胞毒性药物管理的持续质量改进。

方法

首先,开发并验证了自我评估工具细胞毒性药物安全评估工具(Cyto-SAT)。查阅了细胞毒性药物安全处理的关键资料来源,以得出涉及该过程各个阶段安全和质量方面的项目。进行了两轮在线德尔菲调查,以验证项目并确定其优先级。第一轮和第二轮的验证规则分别定义为≥65%和≥75%的一致性。然后,LMICs医疗机构的目标用户在试点测试中对Cyto-SAT工具进行了评估。他们被要求填写一份在线评估问卷。

结果

来自13个高收入国家和LMICs的27名专家参与了德尔菲调查。137个项目中的134个(97.8%)达成了最终专家共识。134个项目中的52个(38.8%)在优先级上达成了共识。最终的Cyto-SAT工具包括10个领域和28个子领域的134个项目,涵盖了整个细胞毒性药物处理过程(https://pharmed.datapharma.ch/cyto-sat_en/)。来自28个LMICs的34个机构的工作人员完成了Cyto-SAT评估。几乎所有人都报告完全同意或同意其有用性(96%)、适用性(94%)、可用性(98%)和可接受性(97%)。

结论

Cyto-SAT是首个旨在协助LMICs专业人员安全处理细胞毒性药物的自我评估工具。试点测试表明,Cyto-SAT是一个有用且备受赞赏的工具,有助于LMICs改进实践。Cyto-SAT将用于一项国际调查,以全面了解不同LMICs环境下的处理实践情况。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验